Metastatic breast cancer patient Claudia shares her experience with ESR1 mutation testing and liquid biopsy: impact on treatment and access barriers. Read More
CPE’s EWAC 2024 webinar on treatment innovation inequalities: targeted therapies, immunotherapy access, and EU policy recommendations. Read More
CPE’s EWAC 2024 webinar on diagnostic inequalities in Europe: genomic testing, liquid biopsy access, and policy recommendations for EU institutions. Read More
CPE factsheet explains combination therapies for cancer patients: how they work, why they’re used, side effects, and questions to ask your oncology team. Read More
CPE’s guide explains personalised medicine for cancer patients: genomic testing, biomarkers, targeted therapies, and how to access precision oncology across Europe. Read More
QUALITOP consortium’s final conference report documents 4 years of EU research on quality of life in cancer immunotherapy, including Smart Digital Platform development. Read More
CPE, MEPs, and researchers call on EU policymakers to harness Real-World Evidence to improve health outcomes, regulatory decisions, and access to medicines.
Read More
ThermoBreast EU project survey invites women to share breast screening experiences to inform development of non-invasive, radiation-free detection technology. Read More
CPE’s survey on ESR1 mutations and liquid biopsy awareness among metastatic breast cancer patients across 5 EU countries informed the 2025 White Paper. Read More
QUALITOP consortium’s final conference report documents 4 years of EU research on quality of life in cancer immunotherapy, including Smart Digital Platform development. Read More